Embryonal Tumor with Multilayered Rosettes Located in the Brainstem: Promising Results After Multimodal Treatment Including Interstitial Brachytherapy
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Juhnke B, Gessi M, Gerber N, Friedrich C, Mynarek M, von Bueren A
. Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. Neuro Oncol. 2021; 24(1):127-137.
PMC: 8730753.
DOI: 10.1093/neuonc/noab100.
View
2.
Korshunov A, Ryzhova M, Jones D, Northcott P, van Sluis P, Volckmann R
. LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol. 2012; 124(6):875-81.
PMC: 3508282.
DOI: 10.1007/s00401-012-1068-3.
View
3.
Lambo S, Grobner S, Rausch T, Waszak S, Schmidt C, Gorthi A
. The molecular landscape of ETMR at diagnosis and relapse. Nature. 2019; 576(7786):274-280.
PMC: 6908757.
DOI: 10.1038/s41586-019-1815-x.
View
4.
Ruge M, Simon T, Suchorska B, Lehrke R, Hamisch C, Koerber F
. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome. J Clin Oncol. 2011; 29(31):4151-9.
DOI: 10.1200/JCO.2011.37.3381.
View
5.
von Hoff K, Haberler C, Schmitt-Hoffner F, Schepke E, de Rojas T, Jacobs S
. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study. Neuro Oncol. 2021; 23(9):1597-1611.
PMC: 8408859.
DOI: 10.1093/neuonc/noab136.
View